Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Ingrid Grunert
Introduction
Ingrid Grunert is a notable inventor based in Penzberg, Germany. She has made significant contributions to the field of glycoengineering, particularly in the modification of antibodies. With a total of 2 patents, her work has advanced the understanding and application of enzymatic processes in biotechnology.
Latest Patents
Ingrid's latest patents include innovative methods for the enzymatic preparation of antibodies with modified glycosylation in the Fc-region. One patent details a method for the re-use of enzymes in in vitro glycoengineering of antibodies. This method involves incubating an antibody with specific enzymes to modify its glycosylation, followed by chromatography steps to separate the modified antibody from the enzymes. Another patent outlines a method for in vitro glycoengineering that includes incubating a monoclonal antibody with enzymes to achieve a defined glycosylation form, followed by recovery and separation processes.
Career Highlights
Throughout her career, Ingrid has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative techniques in antibody modification.
Collaborations
Ingrid has collaborated with various professionals in her field, including her coworker Roberto Falkenstein. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Ingrid Grunert's contributions to the field of glycoengineering are noteworthy, and her patents reflect her innovative approach to antibody modification. Her work continues to influence the biotechnology industry and pave the way for future advancements.